Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hein P. J. Visser"'
Autor:
Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 704-717 (2022)
Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international consensus on a preferred first line treatment approa
Externí odkaz:
https://doaj.org/article/82f4cd8b98654e7fb1dcdbb12f8fdac0
Autor:
Sabine Haggenburg, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, Abraham Goorhuis, Koen De Heer
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1201 (2023)
Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend vaccination with the 13-valent pneumococcal conjugated vacci
Externí odkaz:
https://doaj.org/article/c65a3f49f770442dbbaeaa02436e3d61
Autor:
Doreen G Te, Raa, Lina, van der Straten, Michel, van Gelder, Sabina, Kersting, Mark-David, Levin, Rogier, Mous, Hanneke M, van der Straaten, Marten R, Nijziel, Ellen, van der Spek, Eduardus F M, Posthuma, Hein P J, Visser, Marjolein, van der Klift, Koen, de Heer, Mar, Bellido, Jeanette K, Doorduijn, Anke H W, Bruns, Reinier A P, Raijmakers, Arnon P, Kater
Publikováno v:
HOVON CLL study group 2022, ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ', Leukemia and Lymphoma, vol. 63, no. 10, pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731
Management of patients with chronic lymphocytic leukemia (CLL) is changing due to considerable advances in the therapeutic armamentarium, and new therapies will possibly continue to emerge in the near future. Therefore, the CLL working group of the D
Autor:
Heer, Sabine Haggenburg, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, Abraham Goorhuis, Koen De
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1201
Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend vaccination with the 13-valent pneumococcal conjugated vacci
Autor:
Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Anne-Marie F van der Kevie-Kersemaekers, Ludo M Evers, Fransien de Boer, Harry R Koene, John Schreurs, Marjolein van der Klift, Gerjo A Velders, Ellen van der Spek, Hanneke M van der Straaten, Mels Hoogendoorn, Michel van Gelder, Eduardus F M Posthuma, Hein P J Visser, Ilse Houtenbos, Cecile A M Idink, Djamila E Issa, Ellen C Dompeling, Henk C T van Zaanen, Hendrik Veelken, Henriette Levenga, Lidwine W Tick, Wim E Terpstra, Sanne H Tonino, Michelle Boyer, Mehrdad Mobasher, Mark-David Levin, Arnon P Kater
Publikováno v:
The Lancet Haematology, 9(3), e190-e199. Lancet Publishing Group
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTD
The Lancet Haematology, 9(3), E190-E199. ELSEVIER SCI LTD
Background Fixed-duration 12 cycles of venetoclax plus obinutuzumab is established as first-line treatment for patients with chronic lymphocytic leukaemia. We aimed to determine the activity and safety of 12 cycles of venetoclax consolidation after f
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
Autor:
Chris J.L.M. Meijer, Frank M. Raaphorst, Hanneke C. Kluin-Nelemans, M. J. Gunster, Arie P. Otte, Erik M. M. Manders, Hein P. J. Visser, Roel Willemze
Publikováno v:
British Journal of Haematology. 112:950-958
Polycomb group (PcG) proteins are involved in the stable transmittance of the repressive state of their gene targets throughout the cell cycle. Mis-expression of PcG proteins can lead to proliferative defects and tumorigenesis. There are two separate
Publikováno v:
The Breast Journal. 16:675-677
Publikováno v:
The breast journal. 16(6)